Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Allergy Therapeutics plc
Life Sciences
Consistent first-half revenue growth
By
Dr Martin Hall
09 Mar 2020
Privatisation: Whose flame has burnt the brightest?
By
Nigel Hawkins
03 Mar 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Pantheon International Plc
Financials
2020 interim results: consistency in delivery
By
Mark Thomas
02 Mar 2020
The Monthly: March 2020
02 Mar 2020
Primary Health Properties
Property
Final results show accelerating rental growth
By
Mike Foster
28 Feb 2020
Diurnal Group Plc
Life Sciences
… and more to come (news flow)
28 Feb 2020
Burford Capital
Financials
Mixture of strong and weak activity in 2019
By
Dr Brian Moretta
26 Feb 2020
Titon Holdings
Building & Construction
Condititoning
24 Feb 2020
City of London Investment Group
Financials
Interim results validate good first half performance
By
Dr Brian Moretta
21 Feb 2020
Arix Bioscience
Life Sciences
With high risk can come high reward
19 Feb 2020
Neodecortech
Consumer
Well placed for 2020
By
Jason Streets
18 Feb 2020
Prev
1
...
40
41
42
43
44
...
78
Next
